Crystal structure of human catecholamine sulfotransferase

Journal of Molecular Biology

Volumn 293, Issue 3, 1999, Pages 521-530

  Bidwell, Lisa M ^a   McManus, Michael E ^a   Gaedigk, Andrea ^b   Kakuta, Yoshimitsu ^c   Negishi, Masa ^c   Pedersen, Lars ^c   Martin, Jennifer L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CHILDREN S MERCY HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Catecholamine; Dopamine; Protein structure; Sulfotransferase; SULT1A3

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; ESTROGEN; HEPARAN; HORMONE; NEUROTRANSMITTER; NORADRENALIN; STEROID; SULFOTRANSFERASE;

ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; LIGAND BINDING; PRIORITY JOURNAL;

EID: 0032740346     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3153     Document Type: Article

References (51)

1. Bond C. S., Clements P. R., Ashby S. J., Collyer C. A., Harrop S. J., Hopwood J. J., Guss J. M. Structure of a human lysosomal sulfatase. Structure. 5:1997;277-289.
2. Brix L. A., Barnett A., Duggleby R. G., McManus M. E. Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies. Biochemistry. 38:1999a;10474-10479.
3. Brix L. A., Duggleby R. G., Gaedigk A., McManus M. E. Structural characterization of human aryl sulphotransferases. Biochem. J. 337:1999b;337-343.
4. Brünger A. T. X-PLOR Version 3.1 Manual. 1992;Yale University Press, New Haven.
5. Buu N. T., Duhaime J., Kuchel O. The bicuculline-like properties of dopamine sulfate in rat brain. Life Sci. 35:1984;1083-1090.
6. Cowtan K. Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography. 1994;. p. 34-38.
7. Crawford J. L., Lipscomb W. N., Schellman C. G. The reverse turn as a polypeptide conformation in globular proteins. Proc. Natl Acad. Sci. USA. 70:1973;538-542.
8. Dajani R., Hood A. M., Coughtrie M. W. H. A single amino acid, Glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. Mol. Pharmacol. 54:1998;942-948.
9. Evans S. V. SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11:1993;134-138.
10. Falany C. N. Enzymology of human cytosolic sulfotransferases. FASEB J. 11:1997;206-216.
11. Falany C. N., Vazquez M. E., Kalb J. M. Purification and characterization of human liver dehydroepiandrosterone sulphotransferase. Biochem. J. 260:1989;641-646.
12. Falany C. N., Vazquez M. E., Heroux J. A., Roth J. A. Purification and characterization of human liver phenol-sulfating phenol sulfotransferase. Arch. Biochem. Biophys. 278:1990;312-318.
13. Fritag S., Le Trong I., Klumb L., Stayton P. S., Stenkamp R. E. Structural studies on the streptavidin binding loop. Protein Sci. 6:1997;1157-1166.
14. Fukuta M., Kobayashi Y., Uchimura K., Kimata K., Habuchi H. Molecular cloning and expression of human chondroitin 6-sulfotransferase. Biochim. Biophys. Acta. 1399:1998;57-61.
15. Gaedigk A., Lekas P., Berchuk M., Grant D. M. Novel sulfotransferases cloned by RT-PCR: real proteins or PCR artifacts? Chem. Biol. Interact. 109:1998;43-52.
16. Gillam E. M. J., Baba T., Kim B.-R., Ohmori S., Guengerich F. P. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305:1993;123-131.
17. Goldstein D. S., Lenders J. W. M., Kaler S. G., Eisenhofer G. Catecholamine phenotyping: clues to the diagnosis, treatment, and pathophysiology of neurogenetic disorders. J. Neurochem. 67:1996;1781-1790.
18. Hashimoto Y., Orellana A., Gil G., Hirschberg C. B. Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase. J. Biol. Chem. 267:1992;15744-15750.
19. Honke K., Tsuda M., Hirahara Y., Ishii A., Makita A., Wada Y. Molecular cloning and expression of cDNA encoding human 3′-phosphoadenylylsulfate:galactosylceramide 3′-sulfotransferase. J. Biol. Chem. 272:1997;4864-4868.
20. Johnson G. A., Baker C. A., Smith R. T. Radioenzymatic assay of sulfate conjugates of catecholamines and DOPA in plasma. Life Sci. 26:1980;1591-1598.
21. Jones T. A., Zou J. Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119.
22. Kakuta Y., Pedersen L. G., Carter C. W., Negishi M., Pedersen L. C. Crystal structure of estrogen sulphotransferase. Nature Struct. Biol. 11:1997;904-908.
23. Kakuta Y., Pedersen L. G., Pedersen L. C., Negishi M. Conserved structural motifs in the sulfotransferase family. Trends Biochem. Sci. 23:1998a;129-130.
24. Kakuta Y., Petrotchenko E. V., Pedersen L. C., Negishi M. The sulfuryl transfer mechanism; crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysis. J. Biol. Chem. 273:1998b;27325-27330.
25. Kakuta Y., Sueyoshi T., Negishi M., Pedersen L. C. Crystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/N-sulfotransferase-1. J. Biol. Chem. 274:1999;10673-10676.
26. Komatsu K., Driscoll W. J., Koh Y. C., Strott C. A. A P-loop related motif (GxxGxxK) highly conserved in sulfotransferases is required for binding the activated sulfate donor. Biochem. Biophys. Res. Commun. 204:1994;1178-1185.
27. Kraulis P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
28. Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: Conformational disorder mediates binding diversity. Proc. Natl Acad. Sci. USA. 93:1996;11504-11509.
29. Kuchel O., Buu N. T., Hamet P., Larochelle P., Bourque M., Genest J. Essential hypertension with low conjugated catecholamines imitates pheochromocytoma. Hypertension. 3:1981;347-355.
30. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
31. Littlewood J., Glover V., Sandler M., Petty R., Peatfield R., Rose F. C. Platelet phenolsulphotransferase deficiency in dietary migraine. Lancet. 1:1982;983-986.
32. Lukatela G., Krauss N., Theis K., Selmer T., Gieselmann V., von Figura K., Saenger W. Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry. 37:1998;3654-3664.
33. Mande S. C., Mainfroid V., Kaklk K. H., Goraj K., Martial J. A., Hol W. G. J. Crystal structure of recombinant human triosephosphate isomerase at 2.8 Å resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme. Protein Sci. 3:1994;810-821.
34. Mao X., Barger S. W. Neuroprotection by dehydropiandrosterone sulfate: role of an NFKB-like factor. Neuropharmacology. 9:1998;759-763.
35. Marazziti D., Hollander E., Lensi P., Ravagli S., Cassano G. B. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder. Psych. Res. 42:1992;41-51.
36. Marazziti D., Palego L., Dell'Osso L., Batistini A., Cassano G. B., Akiskal H. S. Platelet sulfotransferase in different psychiatric disorders. Psych. Res. 65:1996;73-78.
37. Marsolais F., Varin L. Identification of amino acid residues critical for catalysis and cosubstrate binding in the flavonol 3-sulfotransferase. J. Biol. Chem. 270:1995;30458-30463.
38. Marsolais F., Varin L. Mutational analysis of domain II of flavonol 3-sulfotransferase. Eur. J. Biochem. 247:1997;1056-1062.
39. Merrit E. A., Murphy M. E. P. Raster3D version 2.0: a program for photorealistic molecular graphics. Acta Crystallog. sect. D. 50:1994;869-873.
40. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
41. Niehrs C., Huttner W. B. Purification and characterization of tyrosylprotein sulfotransferase. EMBO J. 9:1990;35-42.
42. Ong E., Yeh J. C., Ding Y., Hindsgaul O., Fukuda M. Expression cloning of a human sulfotransferase that directs the synthesis of the HNK-1 glycan on the neural cell adhesion molecule and glycolipids. J. Biol. Chem. 273:1998;5190-5195.
43. Orellana A., Hirschberg C. B., Wei Z., Swiedler S. J., Ishihara M. Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line. J. Biol. Chem. 269:1994;2270-2276.
44. Otwinowski Z. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
45. Schreuder H. A., Knight S., Curmi P. M., Andersson I., Casio D., Brändén C.-I., Eisenberg D. Formation of the active site of ribulose-1,5-bisphosphate carboxylase/oxygenase by a disorder-order transition from the unactivated state to the activated form. Proc. Natl Acad. Sci. USA. 90:1993;9968-9972.
46. 614 in the sulfotransferase activity of human heparan sulfate N-deacetylase/N-sulfotransferase. FEBS Letters. 433:1998;211-214.
47. Veronese M. E., Burgess W., Zhu X., McManus M. E. Functional characterisation of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies. Biochem. J. 302:1994;497-502.
48. Vriend G., Sander C. Quality control of protein models: directional atomic contact analysis. J. Appl. Crystallog. 26:1993;47-60.
49. Weinshilboum R. M., Otterness D. M., Aksoy I. A., Wood T. C., Her C., Raftogianis R. B. Sulfotransferase molecular biology: cDNAs and genes. FASEB J. 11:1997;3-14.
50. Yoshizumi M., Kitagawa T., Hori T., Katoh I., Houchi H., Ohuchi T., Oka M. Physiological significance of plasma sulfoconjugated dopamine in patients with hypertension - clinical and experimental studies. Life Sci. 59:1996;323-330.
51. Zhu X., Veronese M. E., Bernard C. C. A., Sansom L. N., McManus M. E. Identification of two human brain aryl sulfotransferase cDNAs. Biochem. Biophys. Res. Commun. 195:1993;120-127.